XevaDB enables AI-driven longitudinal pharmacogenomic modeling in patient-derived xenografts

Patient-derived xenografts (PDXs) are critical models for translational oncology, but their computational use is limited by fragmented pharmacogenomic data, inconsistent response annotations, and poor access to raw longitudinal tumour-volume measurements. Here we present XevaDB (xevadb.ca), a standardized platform designed to support machine learning (ML) and artificial intelligence (AI) applications through the integration of longitudinal treatment and control-arm tumour growth curves with harmonized drug and gene annotations, response metrics, replicate-level experimental design, clinical annotation, and matched molecular profiles. XevaDB provides access to data from 689 PDX models across six tumour types, 69 drugs, 4,828 treatment-control experiments, and matched RNA-seq, copy-number, and mutation data for 337 models. Through four case studies, we show that preserving raw longitudinal response data enables analyses beyond conventional static endpoints: transcriptomic prediction of intrinsic tumour growth, image-based deep learning of drug-response trajectories, replicate-aware transfer learning from cell-line-trained models, and multi-omics prediction of paclitaxel response. These results establish XevaDB as a resource for sharing standardized longitudinal pharmacogenomic data and enabling reproducible AI/ML modeling, demonstrating how integrated PDX data can accelerate computational approaches in preclinical cancer research.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11356792/v1
Primary Topic
Cancer Genomics and Diagnostics
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

XevaDB enables AI-driven longitudinal pharmacogenomic modeling in patient-derived xenografts

Mitchell J. Elliott, Arvind Singh Mer, Jennifer Cruickshank, Jennifer Silvester et al.
Research Square
Cancer Genomics and Diagnostics
preprint

XevaDB enables AI-driven longitudinal pharmacogenomic modeling in patient-derived xenografts

Mitchell J. Elliott, Arvind Singh Mer, Jennifer Cruickshank, Jennifer Silvester, Nhu‐An Pham, Samah El Ghamrasni, David W. Cescon, Aaron Dou, Guanqiao Feng, Ming‐Sound Tsao, Chantal Tobin, Geneviève Deblois, Nikolina Radulovich, Morag Park, Matthew Boccalon, Benjamin Haibe-Kains, Meghan Mcguire, Hellen Kuasne, Taylor Bird, Michael Tran, Sisira Kadambat Nair, Quan Li
preprint en

Abstract

Patient-derived xenografts (PDXs) are critical models for translational oncology, but their computational use is limited by fragmented pharmacogenomic data, inconsistent response annotations, and poor access to raw longitudinal tumour-volume measurements. Here we present XevaDB (xevadb.ca), a standardized platform designed to support machine learning (ML) and artificial intelligence (AI) applications through the integration of longitudinal treatment and control-arm tumour growth curves with harmonized drug and gene annotations, response metrics, replicate-level experimental design, clinical annotation, and matched molecular profiles. XevaDB provides access to data from 689 PDX models across six tumour types, 69 drugs, 4,828 treatment-control experiments, and matched RNA-seq, copy-number, and mutation data for 337 models. Through four case studies, we show that preserving raw longitudinal response data enables analyses beyond conventional static endpoints: transcriptomic prediction of intrinsic tumour growth, image-based deep learning of drug-response trajectories, replicate-aware transfer learning from cell-line-trained models, and multi-omics prediction of paclitaxel response. These results establish XevaDB as a resource for sharing standardized longitudinal pharmacogenomic data and enabling reproducible AI/ML modeling, demonstrating how integrated PDX data can accelerate computational approaches in preclinical cancer research.

Research Square
University Health Network (CA), University of Ottawa (CA), University of Toronto (CA), Princess Margaret Cancer Centre (CA), McGill University (CA), Université de Montréal (CA)
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon